131 related articles for article (PubMed ID: 35901016)
21. Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis.
Wang Z; Luo J; Zhang Y; Xun P; Chen Z
PLoS One; 2022; 17(7):e0271038. PubMed ID: 35901016
[TBL] [Abstract][Full Text] [Related]
22. Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis.
Xie H; Li M; Zheng Y
Gynecol Oncol; 2024 Mar; 182():15-23. PubMed ID: 38246042
[TBL] [Abstract][Full Text] [Related]
23. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
[No Abstract] [Full Text] [Related]
24. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
25. Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.
Tseng CH
PLoS One; 2014; 9(10):e109852. PubMed ID: 25303400
[TBL] [Abstract][Full Text] [Related]
26. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis.
Shuai Y; Li C; Zhou X
Clin Transl Oncol; 2020 Sep; 22(9):1580-1590. PubMed ID: 32060719
[TBL] [Abstract][Full Text] [Related]
27. Association Between Aggressive Clinicopathologic Features of Papillary Thyroid Carcinoma and Body Mass Index: A Systematic Review and Meta-Analysis.
Economides A; Giannakou K; Mamais I; Economides PA; Papageorgis P
Front Endocrinol (Lausanne); 2021; 12():692879. PubMed ID: 34276564
[TBL] [Abstract][Full Text] [Related]
28. The global burden of thyroid cancer and its attributable risk factor in 195 countries and territories: A systematic analysis for the Global Burden of Disease Study.
Zhai M; Zhang D; Long J; Gong Y; Ye F; Liu S; Li Y
Cancer Med; 2021 Jul; 10(13):4542-4554. PubMed ID: 34002931
[TBL] [Abstract][Full Text] [Related]
29. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments.
McGuinness LA; Higgins JPT
Res Synth Methods; 2021 Jan; 12(1):55-61. PubMed ID: 32336025
[TBL] [Abstract][Full Text] [Related]
30. Metformin Use and the Risk of Cancer in Patients with Diabetes: A Nationwide Sample Cohort Study.
Oh TK; Song IA
Cancer Prev Res (Phila); 2020 Feb; 13(2):195-202. PubMed ID: 31699707
[TBL] [Abstract][Full Text] [Related]
31. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.
Cumpston M; Li T; Page MJ; Chandler J; Welch VA; Higgins JP; Thomas J
Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000142. PubMed ID: 31643080
[No Abstract] [Full Text] [Related]
32. Geographic influences in the global rise of thyroid cancer.
Kim J; Gosnell JE; Roman SA
Nat Rev Endocrinol; 2020 Jan; 16(1):17-29. PubMed ID: 31616074
[TBL] [Abstract][Full Text] [Related]
33. Screening for differentiated thyroid cancer in selected populations.
Lamartina L; Grani G; Durante C; Filetti S; Cooper DS
Lancet Diabetes Endocrinol; 2020 Jan; 8(1):81-88. PubMed ID: 31591051
[TBL] [Abstract][Full Text] [Related]
34. Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences.
Fontaine E
Front Endocrinol (Lausanne); 2018; 9():753. PubMed ID: 30619086
[TBL] [Abstract][Full Text] [Related]
35. The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth.
Amin S; Lux A; O'Callaghan F
Br J Clin Pharmacol; 2019 Jan; 85(1):37-46. PubMed ID: 30290005
[TBL] [Abstract][Full Text] [Related]
36. Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy.
Noh Y; Jeon SM; Shin S
Int J Cancer; 2019 Apr; 144(7):1530-1539. PubMed ID: 30229901
[TBL] [Abstract][Full Text] [Related]
37. Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea.
Cho YY; Kang MJ; Kim SK; Jung JH; Hahm JR; Kim TH; Nam JY; Lee BW; Lee YH; Chung JH; Song SO; Kim SW
Thyroid; 2018 Jul; 28(7):864-870. PubMed ID: 29808777
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
